Sunao Sugita1, Manabu Ogawa2, Shizu Inoue2, Norio Shimizu3, Manabu Mochizuki2. 1. Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. sunaoph@tmd.ac.jp. 2. Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. 3. Department of Virology, Medical Research Institute, Tokyo Medical and Dental University Graduate School of Medicine and Dental Sciences, Tokyo, Japan.
Abstract
AIM: To establish a two-step polymerase chain reaction (PCR) diagnostic system for ocular toxoplasmosis. METHODS: A total of 13 ocular fluid samples (11 aqueous humor and 2 vitreous fluid) were collected from 13 patients with clinically suspected ocular toxoplasmosis. Ten ocular samples from other uveitis patients and 20 samples from subjects without ocular inflammation were used as controls. Two polymerase chain reaction (PCR) methods, i.e., qualitative multiplex PCR and quantitative real-time PCR, were used to measure the toxoplasma genome (T. gondii B1 gene). RESULTS: Qualitative multiplex PCR detected T. gondii B1 gene in the ocular fluids of 11 out of 13 patients with clinically suspected ocular toxoplasmosis. In real-time PCR, we detected high copy numbers of T. gondii DNA (5.1 × 10(2)-2.1 × 10(6) copies/mL) in a total of 10 patients (10/13, 77%). Only ocular toxoplasmosis scar lesions were observed in the three real-time PCR-negative patients. PCR assay results for the samples from the two control groups were all negative. CONCLUSIONS: The two-step PCR examination to detect toxoplasma DNA is a useful tool for diagnosing ocular toxoplasmosis.
AIM: To establish a two-step polymerase chain reaction (PCR) diagnostic system for ocular toxoplasmosis. METHODS: A total of 13 ocular fluid samples (11 aqueous humor and 2 vitreous fluid) were collected from 13 patients with clinically suspected ocular toxoplasmosis. Ten ocular samples from other uveitispatients and 20 samples from subjects without ocular inflammation were used as controls. Two polymerase chain reaction (PCR) methods, i.e., qualitative multiplex PCR and quantitative real-time PCR, were used to measure the toxoplasma genome (T. gondii B1 gene). RESULTS: Qualitative multiplex PCR detected T. gondii B1 gene in the ocular fluids of 11 out of 13 patients with clinically suspected ocular toxoplasmosis. In real-time PCR, we detected high copy numbers of T. gondii DNA (5.1 × 10(2)-2.1 × 10(6) copies/mL) in a total of 10 patients (10/13, 77%). Only ocular toxoplasmosis scar lesions were observed in the three real-time PCR-negative patients. PCR assay results for the samples from the two control groups were all negative. CONCLUSIONS: The two-step PCR examination to detect toxoplasma DNA is a useful tool for diagnosing ocular toxoplasmosis.
Authors: Jolanda D F De Groot-Mijnes; Aniki Rothova; Anton M Van Loon; Margje Schuller; Ninette H Ten Dam-Van Loon; Joke H De Boer; Rob Schuurman; Annemarie J L Weersink Journal: Am J Ophthalmol Date: 2006-02 Impact factor: 5.258
Authors: A Kijlstra; L Luyendijk; G S Baarsma; A Rothova; C M Schweitzer; Z Timmerman; J de Vries; A C Breebaart Journal: Int Ophthalmol Date: 1989-12 Impact factor: 2.031
Authors: Deise F Costa; Heloisa Nascimento; Aline Sutili; Fernando A J Nobrega; Flavio Fowler; Mario Junqueira Nobrega; Cristina Garrido; Janaina de Oliveira Dias; Consuelo B D Adán; Luiz Vicente Rizzo; Claudio Silveira; Rubens Belfort; Alessandra G Commodaro Journal: Parasitol Res Date: 2017-05-15 Impact factor: 2.289
Authors: Marius A Scheepers; Karin A Lecuona; Graeme Rogers; Catey Bunce; Craig Corcoran; Michel Michaelides Journal: ScientificWorldJournal Date: 2013-10-22